Bioanalysis, biomarker assay development, validation and sample analysis.
Drug development and manufacturing for biologics and small molecules, with integrated services from preclinical, clinical to commercial.
Best-in-class drug discovery products and services to identify and develop life-changing therapies.
Global insourcing solutions delivering on-site scientific and laboratory services.
Delivering safety, efficacy, biomarker, and pathology services, through a global network of CAP accredited laboratories.
Solutions from discovery through commercialisation.
With facilities in Europe, North America and Asia, we support clients in the pharma, diagnostics, food, agriculture, biotechnological and research markets.
Comprehensive BioPharma Product Testing: a leader in testing biologics, CGT, nucleic acid therapies, and small molecules from early developm…
With over 40 years of expertise and capabilities, Eurofins Medical Device Services offers comprehensive solutions across the entire medical…
Jon S. Kauffman, PhD, Vice President, Biologics Testing, Eurofins BioPharma Product Testing US; Elise Richard, Technical Committee Project Manager, Eurofins BioPharma Product Testing Europe
The Eurofins BioPharma Product Testing (EBPT) Global Technical Councils are comprised of Eurofins subject matter experts (SMEs) from sites across the US, EU and Asia. In 2022, the main active councils and sub councils/working groups held approximately 70 meetings, covering challenges affecting: Biologics (Biochromatography, Potency, Electrophoresis), Cell & Gene Therapy (ddPCR, Chromatography, Replication Competent Assays, Residual Impurities), Compendial, Microbiology, Qualified Persons (EU Only), Dissolution, Metrology, New Buildings, Medical Services (Consultancy, Chemical Characterisation).
These effective and valuable forums assemble SMEs to collaborate, harmonise, strategise and troubleshoot. The goal is building inter-laboratory relationships to share knowledge and experience across our extensive laboratory network. Councils have developed harmonised approaches and guidelines with regards to regulatory requirements (Annex 1 tool for gap analysis) and method transfers, and have drafted white papers, webinars and training materials. Another positive outcome is the ability to develop a strategy for investments and new method and service implementation as a result of identifying trends in the industry and new technologies at a global level.
Ultimately, these technical councils allow us to better serve our clients. Any site can bring forward an analytical or regulatory issue to the broader group, as an ideal troubleshooting platform. There is a high probability that another site has already faced a similar issue and can offer a quick resolution. For example, since the pandemic, an increased frequency of supply chain and quality issues have been observed with critical laboratory consumables (standards, kits, reagents and columns). In most situations, one EBPT laboratory has already encountered the same situation and can save the other EBPT laboratories valuable time by sharing root causes and offering suggestions and alternatives. This allows us to sustain support of our clients’ supply chain and provide their valuable products to the patients that need them. For more information, contact your Project Manager.